Alzheimer's drug TB006 safety trial halted early
NCT ID NCT05476783
First seen May 07, 2026 · Last updated May 07, 2026
Summary
This study looked at the long-term safety of a drug called TB006 in people with Alzheimer's disease. It included people who had already been in a previous TB006 study and new participants. The study was stopped early, and its main goal was to track side effects and how the drug moves through the body.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER'S DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinical Trial Site
San Diego, California, 92103, United States
-
Clinical Trial Site
Delray Beach, Florida, 33445, United States
-
Clinical Trial Site
Lady Lake, Florida, 32159, United States
-
Clinical Trial Site
Maitland, Florida, 32751, United States
-
Clinical Trial Site
Miami, Florida, 33135, United States
-
Clinical Trial Site
Miami, Florida, 33137, United States
-
Clinical Trial Site
Miami, Florida, 33165, United States
-
Clinical Trial Site
West Palm Beach, Florida, 33407, United States
-
Clinical Trial Site
Winter Park, Florida, 32789, United States
-
Clinical Trial Site
Winter Park, Florida, 32792, United States
-
Clinical Trial Site
Decatur, Georgia, 30030, United States
-
Clinical Trial Site
Matthews, North Carolina, 28105, United States
-
Clinical Trial Site
Fairfax, Virginia, 22031, United States
Conditions
Explore the condition pages connected to this study.